News & Updates

Hormone Replacement Therapy (H.R.T) Class Action

We are pleased to report that Madam Justice Gropper of the British Columbia Supreme Court certified this lawsuit as a class action on August 4, 2011. This means that the case can move forward to trial. A copy of her decision can be found here. News items related to the case are below.

We are pleased to report that the Court of Appeal upheld Madam Justice Gropper’s ruling that the British Columbia courts have jurisdiction over the U.S. defendants. The certification hearing is scheduled to be heard on December 15 to 17, 2010.

2011

1 Sep CBC Radio: Medical Ghostwriting (266 KB)
12 Aug Class action lawsuit launched from Sechelt (193 KB)
7 Aug Class-action suit OK'd: Breast cancer patients can sue drugmaker (193 KB)
6 Aug Judge certifies class-action lawsuit against hormone therapy drugmakers (72 KB)
6 Aug Class action suit linking drugs, cancer approved (119 KB)
6 Aug Class Action Lawsuit against Wyeth to be Joined by Women in Canada (221 KB)
5 Aug Woman sues after menopause drug gives her breast cancer (221 KB)
5 Aug Court certifies breast cancer class-action lawsuit (382 KB)
5 Aug Class-action breast cancer lawsuit approved (328 KB)
5 Aug HRT class action case on breast cancer OK'd (270 KB)
5 Aug B.C. court certifies breast cancer class action (72 KB).
4 Aug Court Certifies Class Action for Canadian Women Harmed by HRT
(72 KB).
5 Aug B.C. court certifies breast cancer class action (72 KB).
4 Aug Court Certifies Class Action for Canadian Women Harmed by HRT (72 KB)

2009

15 Aug Healthzone.ca: Ghostwriting is bad medicine (45 KB)

2008

30 Jun Media coverage related to Madam Justice Gropper's decision (120 KB)
27 June On June 27, 2008 Madam Justice Gropper issued Reasons for Judgement holding that the American corporate defendants in this lawsuit, all members of the Wyeth pharmaceuticals conglomerate, fall within the jurisdiction of B.C.’s courts and may be held responsible to Canadian consumers. (See February 2007 entry below for further discussion of this issue.) The American defendants have 30 days to decide whether to appeal the decision of Madam Justice Gropper. If they do not, the next significant step in this lawsuit will be the “certification hearing” during which the Plaintiff will request a court order designating this action as a class action. It will be several months before the certification hearing can take place. See the Reasons of Madam Justice Gropper (102 KB) issued June 27, 2008.

2007

Feb Before a lawsuit can be considered a class action, the Plaintiff has to apply to have it “certified” by the court. The certification hearing in this case will not take place until the case management judge, Madam Justice Gropper, has heard a "jurisdiction application" filed by all of the American Defendants. The American Wyeth companies have filed documents with the Supreme Court of British Columbia requesting a stay of this action against them on the grounds that the court has no jurisdiction over them. The date for the hearing of the jurisdiction application is not yet known.
29 Jan Wyeth loses Prempro trial, ordered to pay $1.5 million in damages (73 KB)

2006

22 Dec Canadian, U.S. breast cancer rates drop (89 KB)
20 Dec Reduced hormone therapy use may be cause of steep decline in breast cancer cases (60 KB)
14 Dec Decline in breast cancer cases likely linked to reduced use of hormone replacement (89 KB)

2002

Mar Hormone therapy raises risk of breast cancer recurrence (20 KB)
Jan Canadian Cancer Society announces recommendation about combined hormone replacement therapy (15 KB)
Jan Health Canada: Benefits and risks of combined (estrogen and progestin) Hormone Replacement Therapy (74 KB)

2002

Aug What The Experts are Saying Now: A Round-Up of International Opinion (34 KB)
Jul Increased Risk of Ovarian Cancer Is Linked to Estrogen Replacement Therapy (22 KB)

1995

Mar Postmenopausal Estrogen Therapy and the Risk for Developing Systemic Lupus Erythematosus (72 KB)

Client Testimonial

"I expected you to be quick but that was amazing! Your law firm exceeded my expectations of service and client care. I will recommend your firm to anyone."

— Nicole Sharma